Publication & Citation Trends
Publications
0 total
NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.
Cited by 1
Semantic Scholar
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2 OA
Cited by 8
Semantic Scholar
Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 study.
Cited by 4
Semantic Scholar
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
Cited by 0
Semantic Scholar
526P Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: A FRESCO-2 subgroup analysis by age
Cited by 0
Semantic Scholar
Recommendations on the use of azole antifungals in hematology-oncology patients OA
Cited by 30
Semantic Scholar
LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer OA
Cited by 23
Semantic Scholar
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) OA
Cited by 34
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(23)
Pancreatic and Hepatic Oncology Research
(16)
Gastric Cancer Management and Outcomes
(13)
Cancer Genomics and Diagnostics
(13)
Cancer Treatment and Pharmacology
(9)
Affiliations
Universidad San Pablo CEU
Verizon (United States)
Centro Oncológico de Galicia
HM Hospitales
Hospital Universitario HM Sanchinarro